China Commits To Patent Linkage And Extensions In US Trade Deal

Data Protection Also Included In Deal

The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.   

Trade Deal
Patent linkage and extensions enshrined in a new US-China trade deal • Source: Shutterstock

Commitments to implement a patent-linkage system notifying originators of generic filings as well as patent-term extensions to compensate for regulatory and patent review periods are key measures in a section on pharmaceutical intellectual-property protection included in "Phase One" of a trade agreement signed between China and the US on 15 January.

Pharmaceutical data protection is also included in the deal. (Also see "Trade, IP And Oncology Deals: What You Need...

More from Legal & IP

More from Pink Sheet